Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms-Reference-Cited by-同舟云学术

Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms

Published:2009-04 Issue:4 Volume:81 Page:672-677
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Cotte Laurent,Trabaud Mary-Anne,Tardy Jean-Claude,Brochier Corinne,Gilibert René-Pierre,Miailhes Patrick,Trépo Christian,André Patrice

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference13 articles.

1. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1;Andries;Antimicrob Agents Chemother,2004

2. HIV-1 genotype algorithms for prediction of etravirine susceptibility: Novel mutations and weighting factors identified through correlations to phenotype;Benhamida;Antiviral Ther,2008

3. Increased phenotypic susceptibility to etravirine in HIV-1 with nucleoside reverse transcriptase inhibitor resistance;Benhamida;Antiviral Ther,2008

4. French ANRS AC11 group. 2008. HIV-1 genotypic drug resistance interpretation's algorithms. Table of rules 2008 (v. 17): Non-nucleoside reverse transcriptase inhibitors. Avalaible at: http://www.hivfrenchresistance.org/2008/Algo-2008.pdf.

5. Shifting paradigms: The resistance profile of etravirine;Geretti;J Antimicrob Chemother,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of pretreatment HIV drug resistance in Cameroon following a nationally representative WHO survey;Journal of Antimicrobial Chemotherapy;2018-06-19

2. Etravirine and Rilpivirine Drug Resistance Among HIV-1 Subtype C Infected Children Failing Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens in South India;AIDS Research and Human Retroviruses;2017-06

3. High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic;Medicine;2017-03

4. High Rate Of Antiretroviral Drug Resistance Mutations in HIV Type 1-Infected Senegalese Children in Virological Failure on First-Line Treatment According to the World Health Organization Guidelines;AIDS Research and Human Retroviruses;2013-02

5. Transmitted HIV Resistance to First-Line Antiretroviral Therapy in Lima, Peru;AIDS Research and Human Retroviruses;2012-04